---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-089587"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:28:40.883253+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Fulgent Q2 core revenue $70.2M (+5% YoY); GAAP loss $0.29/share improves EPS guidance

## Summary
- Total revenue $71.0M; core revenue $70.2M (+5% YoY).
- GAAP net loss $8.7M ($0.29 per share); Non-GAAP income $4.7M ($0.15 per share).
- Adjusted EBITDA loss $727K; cash from ops $4.3M; cash and investments $837.9M.
- Reiterates FY2024 core revenue guidance $280M; improves EPS guidance.

## SEC filing metadata
- accession: 0000950170-24-089587
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000095017024089587/0000950170-24-089587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000095017024089587/flgt-20240802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-089587
- JSON: https://secwatch.observer/filing/0000950170-24-089587.json
- Plain text: https://secwatch.observer/filing/0000950170-24-089587.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.